Gentian Diagnostics AS (FRA:6FK) Cyclically Adjusted FCF per Share: €-0.11 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:6FK Gentian Diagnostics AS FRA:6FK
77 GF Score
Price €3.49
GF Value €5.29
Valuation Significantly Undervalued
View Full Analysis

What is Gentian Diagnostics AS Cyclically Adjusted FCF per Share?

Gentian Diagnostics AS FRA:6FK -0.57% 77 Cyclically Adjusted FCF per Share is €-0.11 as of Jun. 2026. GuruFocus rates FRA:6FK with a GF Score™ of 77/100 and a GF Value™ of €5.29 (Significantly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Gentian Diagnostics AS's adjusted free cash flow per share for the three months ended in Jun. 2026 was €-0.019. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-0.11 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-08-26), Gentian Diagnostics AS's current stock price is €3.49. Gentian Diagnostics AS's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was €-0.11. Gentian Diagnostics AS's Cyclically Adjusted Price-to-FCF of today is .


Gentian Diagnostics AS  (FRA:6FK) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Gentian Diagnostics AS Cyclically Adjusted FCF per Share Related Terms


Gentian Diagnostics AS Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Gentian Diagnostics AS's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gentian Diagnostics AS Cyclically Adjusted FCF per Share Chart

Gentian Diagnostics AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.13 -0.10

Gentian Diagnostics AS Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.12 -0.12 -0.10 -0.11 -0.11

FRA:6FK vs ABT, SYK, MDT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Gentian Diagnostics AS's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gentian Diagnostics AS Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gentian Diagnostics AS's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Gentian Diagnostics AS's Cyclically Adjusted Price-to-FCF falls into.


FRA:6FK
77GF Score
Gentian Diagnostics AS FRA:6FK
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gentian Diagnostics AS Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Gentian Diagnostics AS's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.019/141.5800*141.5800
=-0.019

Current CPI (Jun. 2026) = 141.5800.

Gentian Diagnostics AS Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 -0.057 104.200 -0.077
201612 -0.036 104.400 -0.049
201703 -0.201 105.000 -0.271
201706 0.071 105.800 0.095
201709 -0.054 105.900 -0.072
201712 -0.018 106.100 -0.024
201803 -0.127 107.300 -0.168
201806 -0.055 108.500 -0.072
201809 -0.044 109.500 -0.057
201812 0.028 109.800 0.036
201903 -0.049 110.400 -0.063
201906 -0.080 110.600 -0.102
201909 -0.063 111.100 -0.080
201912 0.022 111.300 0.028
202003 -0.058 111.200 -0.074
202006 0.009 112.100 0.011
202009 -0.053 112.900 -0.066
202012 0.001 112.900 0.001
202103 -0.075 114.600 -0.093
202106 -0.044 115.300 -0.054
202109 -0.039 117.500 -0.047
202112 -0.100 118.900 -0.119
202203 -0.091 119.800 -0.108
202206 -0.046 122.600 -0.053
202209 0.018 125.600 0.020
202212 -0.067 125.900 -0.075
202303 -0.025 127.600 -0.028
202306 0.033 130.400 0.036
202309 -0.016 129.800 -0.017
202312 0.068 131.900 0.073
202403 -0.004 132.600 -0.004
202406 -0.018 133.800 -0.019
202409 0.072 133.700 0.076
202412 -0.040 134.800 -0.042
202503 0.025 136.100 0.026
202506 -0.008 137.800 -0.008
202509 0.042 138.500 0.043
202512 0.116 139.100 0.118
202603 -0.073 141.030 -0.073
202606 -0.019 141.580 -0.019

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-0.11 mean?
Gentian Diagnostics AS (FRA:6FK) has a Cyclically Adjusted FCF per Share of €-0.11 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Gentian Diagnostics AS and its competitors.
Is Gentian Diagnostics AS's Cyclically Adjusted FCF per Share too high?
Gentian Diagnostics AS's current Cyclically Adjusted FCF per Share is €-0.11. Overall, Gentian Diagnostics AS has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Gentian Diagnostics AS's Cyclically Adjusted FCF per Share compare to ABT and SYK?
Gentian Diagnostics AS's Cyclically Adjusted FCF per Share of €-0.11 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Gentian Diagnostics AS and its competitors. Gentian Diagnostics AS's current Cyclically Adjusted FCF per Share is €-0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gentian Diagnostics AS stock overvalued right now?
Based on GuruFocus' analysis, Gentian Diagnostics AS (FRA:6FK) is currently considered Significantly Undervalued. The stock's GF Value™ is €5.29, compared to a current price of €3.49 — trading 34% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €-0.11. Gentian Diagnostics AS's overall GF Score™ is 77/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Gentian Diagnostics AS (FRA:6FK), the current Cyclically Adjusted FCF per Share is €-0.11 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gentian Diagnostics AS (FRA:6FK) Overvalued in 2026?

Based on GuruFocus' analysis, Gentian Diagnostics AS stock appears to be undervalued. The current stock price of €3.49 is trading 34% below its estimated GF Value™ of €5.29. GuruFocus considers Gentian Diagnostics AS to be Significantly Undervalued.

Key valuation signals for FRA:6FK:

  • Cyclically Adjusted FCF per Share: €-0.11
  • GF Value™: €5.29 vs. price of €3.49 (34% below fair value)
  • GF Score™: 77/100

No single metric tells the full story. See the FRA:6FK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gentian Diagnostics AS Business Description

Other Exchanges GENTOo:SwedenGENT:Norway
Address Bjornasveien 5, Moss, NOR, 1596
Gentian Diagnostics AS operates as a medical diagnostics company in Norway. It develops and produces in vitro diagnostic reagents (IVD) for medical diagnostics and research. Its portfolio and pipeline of reagents span areas such as inflammation, severe infections, kidney diseases, heart failure, and veterinary healthcare. The company's product portfolio includes the Gentian Cystatin C Immunoassay, the GCAL circulating calprotectin immunoassay (IVDR), the Gentian Retinol Binding Protein (RBP), and the Gentian Canine CRP, among others. Geographically, it generates a majority of its revenue from Europe, followed by Asia and the United States of America.
77GF Score

Get the complete analysis for FRA:6FK

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.49
Price
€5.29
GF Value